跳至主要内容
临床试验/NL-OMON44434
NL-OMON44434已完成不适用

Assessment of new enhanced ostomy devices in real-life settings in subjects having an ileostomy - CP264

Coloplast A/S0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
Coloplast A/S
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Have given written informed consent
  • 2. Be at least 18 years of age and have full legal capacity
  • 3. Have had their ileostomy for at least 3 months
  • 4 .Must be able to use custom cut product
  • 5. Can use a product with max cut size 45 mm
  • 6. Self-reported problems with leakage (3 x within 14 days)
  • 7. Can handle the Clinical App. and product themselves
  • 8. Users get red skin after exposure to output (screening visit)

排除标准

  • 1. Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis)
  • 2. Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid treatment (e.g. injection, or tablet) are allowed.
  • 3. Are participating in other interventional clinical investigations or have previously participated in this investigation. Participation in other Coloplast in-house clinical investigations are accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this (CP264) protocol.
  • 4. Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator)
  • 5. Have known hypersensitivity towards any of the products used in the investigation

研究者

发起方
Coloplast A/S

相似试验